BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 15842990)

  • 1. Usefulness of enalapril versus propranolol or atenolol for prevention of aortic dilation in patients with the Marfan syndrome.
    Yetman AT; Bornemeier RA; McCrindle BW
    Am J Cardiol; 2005 May; 95(9):1125-7. PubMed ID: 15842990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Losartan added to β-blockade therapy for aortic root dilation in Marfan syndrome: a randomized, open-label pilot study.
    Chiu HH; Wu MH; Wang JK; Lu CW; Chiu SN; Chen CA; Lin MT; Hu FC
    Mayo Clin Proc; 2013 Mar; 88(3):271-6. PubMed ID: 23321647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different patterns of aortic wall elasticity in patients with Marfan syndrome: a noninvasive follow-up study.
    Baumgartner D; Baumgartner C; Schermer E; Engl G; Schweigmann U; Mátyás G; Steinmann B; Stein JI
    J Thorac Cardiovasc Surg; 2006 Oct; 132(4):811-9. PubMed ID: 17000292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of perindopril on large artery stiffness and aortic root diameter in patients with Marfan syndrome: a randomized controlled trial.
    Ahimastos AA; Aggarwal A; D'Orsa KM; Formosa MF; White AJ; Savarirayan R; Dart AM; Kingwell BA
    JAMA; 2007 Oct; 298(13):1539-47. PubMed ID: 17911499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary prevention of cardiac events following myocardial infarction: effects of atenolol and enalapril. Beijing Collaborative Study Group.
    Wu N; Fan Z
    Chin Med J (Engl); 1997 Aug; 110(8):602-6. PubMed ID: 9594263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-blocking therapy in patients with the Marfan syndrome and entire aortic replacement.
    Meijboom LJ; Westerhof BE; Nollen GJ; Spaan JA; de Mol BA; Jacobs MJ; Mulder BJ
    Eur J Cardiothorac Surg; 2004 Nov; 26(5):901-6. PubMed ID: 15519180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study of the efficacy and safety of losartan versus atenolol for aortic dilation in patients with Marfan syndrome].
    Forteza A; Evangelista A; Sánchez V; Teixidó G; García D; Sanz P; Gutiérrez L; Centeno J; Rodríguez-Palomares J; Cortina J; García-Dorado D
    Rev Esp Cardiol; 2011 Jun; 64(6):492-8. PubMed ID: 21561700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in aortic distensibility and pulse wave velocity assessed with magnetic resonance imaging following beta-blocker therapy in the Marfan syndrome.
    Groenink M; de Roos A; Mulder BJ; Spaan JA; van der Wall EE
    Am J Cardiol; 1998 Jul; 82(2):203-8. PubMed ID: 9678292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term doxycycline is more effective than atenolol to prevent thoracic aortic aneurysm in marfan syndrome through the inhibition of matrix metalloproteinase-2 and -9.
    Chung AW; Yang HH; Radomski MW; van Breemen C
    Circ Res; 2008 Apr; 102(8):e73-85. PubMed ID: 18388324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review of the pharmacological management of aortic root dilation in Marfan syndrome.
    Thakur V; Rankin KN; Hartling L; Mackie AS
    Cardiol Young; 2013 Aug; 23(4):568-81. PubMed ID: 23083542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of long-term beta-blockade on aortic root compliance in patients with Marfan syndrome.
    Rios AS; Silber EN; Bavishi N; Varga P; Burton BK; Clark WA; Denes P
    Am Heart J; 1999 Jun; 137(6):1057-61. PubMed ID: 10347331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactiv use of propranolol in the Marfan syndrome to prevent aortic dissection.
    Ose L; McKusick VA
    Birth Defects Orig Artic Ser; 1977; 13(3C):163-9. PubMed ID: 19114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical treatment of Marfan syndrome: a time for change.
    Williams A; Davies S; Stuart AG; Wilson DG; Fraser AG
    Heart; 2008 Apr; 94(4):414-21. PubMed ID: 18347371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of atenolol, perindopril and verapamil on haemodynamic and vascular function in Marfan syndrome - a randomised, double-blind, crossover trial.
    Williams A; Kenny D; Wilson D; Fagenello G; Nelson M; Dunstan F; Cockcroft J; Stuart G; Fraser AG
    Eur J Clin Invest; 2012 Aug; 42(8):891-9. PubMed ID: 22471392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective analysis of the effect of angiotensin II receptor blocker versus β-blocker on aortic root growth in paediatric patients with Marfan syndrome.
    Mueller GC; Stierle L; Stark V; Steiner K; von Kodolitsch Y; Weil J; Mir TS
    Heart; 2014 Feb; 100(3):214-8. PubMed ID: 24270746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, double blind pilot study to assess the effects of losartan vs. atenolol on the biophysical properties of the aorta in patients with Marfan and Loeys-Dietz syndromes.
    Sandor GG; Alghamdi MH; Raffin LA; Potts MT; Williams LD; Potts JE; Kiess M; van Breemen C
    Int J Cardiol; 2015 Jan; 179():470-5. PubMed ID: 25465809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-blocker therapy does not alter the rate of aortic root dilation in pediatric patients with Marfan syndrome.
    Selamet Tierney ES; Feingold B; Printz BF; Park SC; Graham D; Kleinman CS; Mahnke CB; Timchak DM; Neches WH; Gersony WM
    J Pediatr; 2007 Jan; 150(1):77-82. PubMed ID: 17188619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence: results of the randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III.
    Willenheimer R; van Veldhuisen DJ; Silke B; Erdmann E; Follath F; Krum H; Ponikowski P; Skene A; van de Ven L; Verkenne P; Lechat P;
    Circulation; 2005 Oct; 112(16):2426-35. PubMed ID: 16143696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Ghent Marfan Trial--a randomized, double-blind placebo controlled trial with losartan in Marfan patients treated with β-blockers.
    Möberg K; De Nobele S; Devos D; Goetghebeur E; Segers P; Trachet B; Vervaet C; Renard M; Coucke P; Loeys B; De Paepe A; De Backer J
    Int J Cardiol; 2012 Jun; 157(3):354-8. PubMed ID: 21239069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Losartan Versus Atenolol for Prevention of Aortic Dilation in Patients With Marfan Syndrome.
    Teixido-Tura G; Forteza A; Rodríguez-Palomares J; González Mirelis J; Gutiérrez L; Sánchez V; Ibáñez B; García-Dorado D; Evangelista A
    J Am Coll Cardiol; 2018 Oct; 72(14):1613-1618. PubMed ID: 30261963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.